Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

<p>Abstract</p> <p>Background</p> <p>Psychostimulants and non stimulants are effective in the treatment of ADHD. Efficacy of both methylphenidate and atomoxetine has been established in placebo controlled trials. Direct comparison of efficacy is now possible due to avai...

Full description

Bibliographic Details
Main Authors:	Hanwella Raveen, Senanayake Madhri, de Silva Varuni
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	BMC Psychiatry
Online Access:	http://www.biomedcentral.com/1471-244X/11/176

Similar Items

Age and sex specific suicide rates in Sri Lanka from 1995-2011
by: Varuni de Silva, et al.
Published: (2013-01-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
by: Dilla Tatiana, et al.
Published: (2009-04-01)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
by: Yoko Nakanishi, et al.
Published: (2017-05-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
by: S King, et al.
Published: (2006-07-01)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
by: Paul Hammerness, et al.
Published: (2009-03-01)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
by: Tsutomu Nagai, et al.
Published: (2022-09-01)

Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD).
by: Su Jin Moon, et al.
Published: (2014-01-01)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
by: Johanne Pereira Ribeiro, et al.
Published: (2021-08-01)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
by: Michael A. Sopko Jr, et al.
Published: (2010-08-01)

Methylphenidate use in children with attention deficit hyperactivity disorder
by: Felipe Salles Neves Machado, et al.
Published: (2015-01-01)

Quality of life of methylphenidate treatment-responsive adolescents with attention-deficit/hyperactivity disorder
by: Pin-Chen Yang, et al.
Published: (2012-05-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Comparative Efficacy of Iranian and Foreign Methylphenidate in Children with Attention Deficit Hyperactive Disorder
by: M Karahmadi, et al.
Published: (2008-04-01)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
by: Rubin Richard, et al.
Published: (2009-12-01)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
by: Reimherr Fred, et al.
Published: (2005-10-01)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
by: Maria Bernarda Pitzianti, et al.
Published: (2020-09-01)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
by: Onur İsmi, et al.
Published: (2018-07-01)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
by: Alekhya Mandali, et al.
Published: (2021-01-01)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
by: Sharon Shem-Tov BSc, et al.
Published: (2019-05-01)

Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
by: Ali Karayağmurlu, et al.
Published: (2022-09-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
by: Serkan Turan, et al.
Published: (2019-10-01)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
by: Clemow DB, et al.
Published: (2017-02-01)

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults
by: François Montastruc, et al.
Published: (2024-04-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
by: Vijaya Kumar, et al.
Published: (2017-01-01)

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials
by: Schacht Alexander, et al.
Published: (2010-12-01)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
by: Anne B. Arnett, et al.
Published: (2022-05-01)

Comparison of duloxetine and methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01)

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians
by: Chris J. Bushe Mbbs, et al.
Published: (2011-01-01)

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
by: Chris J. Bushe MBBS, et al.
Published: (2011-12-01)

Cost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidate.
by: Jurjen van der Schans, et al.
Published: (2015-01-01)

An adolescent boy with kleptomania and attention‐deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report
by: Kensuke Miyazaki, et al.
Published: (2023-12-01)

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
by: Wilfried Pott, et al.
Published: (2013-03-01)

The effect of methylphenidate on pain perception thresholds in children with attention deficit hyperactivity disorder
by: Abdullah Bozkurt, et al.
Published: (2023-10-01)

Methylphenidate-Induced Raynaud’s Phenomenon In Two Cases With Attention-Deficit/Hyperactivity Disorder
by: Ömer Faruk Akça, et al.
Published: (2021-05-01)

Successful treatment of attention-deficit/hyperactivity disorder accompanying to alkaptonuria with methylphenidate and risperidone
by: Asiye Arıcı, et al.
Published: (2019-01-01)

The effect of adding ferrous sulfate to methylphenidate on attention-deficit/hyperactivity disorder in children
by: Gholamreza Panahandeh, et al.
Published: (2017-01-01)

Relationship between using Methylphenidate and Anxiety in children with attention-deficit hyperactivity disorder
by: zahra borjali, et al.
Published: (2012-09-01)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
by: Cao P, et al.
Published: (2018-11-01)